(Q1)May 31, 2024 | (FY)Feb 29, 2024 | (Q1)May 31, 2023 | |
---|---|---|---|
Operating Cash Flow (Indirect Method) | |||
Cash flow from continuing operating activities | -8,195.95%-139.37K | -307.87K | -1.68K |
Net income from continuing operations | -3,189.17%-253.83K | ---320.55K | ---7.72K |
Asset impairment expenditure | --18K | ---- | --0 |
Change In working capital | 1,497.70%96.45K | --12.68K | --6.04K |
-Change in receivables | -3,405.58%-6.91K | ---4.56K | ---197 |
-Change in prepaid assets | ---431 | ---5K | --0 |
-Change in payables and accrued expense | 554.76%40.82K | --85.22K | --6.23K |
-Change in other working capital | --62.97K | ---62.97K | ---- |
Cash from discontinued investing activities | |||
Operating cash flow | -8,195.95%-139.37K | ---307.87K | ---1.68K |
Investing cash flow | |||
Cash flow from continuing investing activities | -68.63K | -18K | 0 |
Net PPE purchase and sale | ---68.63K | ---18K | --0 |
Cash from discontinued investing activities | |||
Investing cash flow | ---68.63K | ---18K | --0 |
Financing cash flow | |||
Cash flow from continuing financing activities | 0 | 786.52K | 96.17K |
Net common stock issuance | --0 | --797.08K | --10K |
Net other financing activities | ---- | ---10.56K | --86.17K |
Cash from discontinued financing activities | |||
Financing cash flow | --0 | --786.52K | --96.17K |
Net cash flow | |||
Beginning cash position | --460.66K | --0 | --0 |
Current changes in cash | -320.14%-208.01K | --460.66K | --94.49K |
End cash Position | 167.40%252.65K | --460.66K | --94.49K |
Free cash from | -12,281.31%-208.01K | ---325.87K | ---1.68K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data